Ashwini K. Devkota

658 citations
23 papers · 513 indexed · h-index 14

Ashwini K. Devkota

23 papers receiving 500 citations

Peers

Ashwini K. Devkota
Comparison fields: 5 of 74
  • Cancer Research 88
  • Molecular Biology 361
  • Complementary and alternative medicine 43
  • Pharmacology 27
  • Computational Theory and Mathematics 43
Replace Haiwei Xu with:
Haiwei Xu China
Mingsong Shi China
Rosa Buonfiglio Italy
Fujun Dai China
Mariano Cárdenas Argentina
Huizhen Zhao China
Long-Shan Li United States
Ya-Ming Xu United States
Madhu Sudhana Saddala United States
Qichao Bao China
Ashwini K. Devkota relative to Haiwei Xu China Haiwei Xu's profile →
Citations per field
00.5×10×20×30×40×48×
Haiwei Xu · 1×
Citations per year

Countries citing papers authored by Ashwini K. Devkota

Since Specialization
Citations

This map shows the geographic impact of Ashwini K. Devkota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwini K. Devkota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwini K. Devkota more than expected).

Fields of papers citing papers by Ashwini K. Devkota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwini K. Devkota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwini K. Devkota. The network helps show where Ashwini K. Devkota may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ashwini K. Devkota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashwini K. Devkota Line = papers co-authored together Ashwini K. Devkota links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20202
2 20198
3 201821
4 20184
5 20177
6 201712
7 201723
8 201668
9 20164
10 201620
11 20153
12 201423
13 201412
14 201322
15 201220
16 201125
17 201135
18 201132
19 200616
20 200345

About Ashwini K. Devkota

Ashwini K. Devkota is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 23 papers that have together received 513 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Click Chemistry and Applications (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Chemical Synthesis and Analysis (3 papers), Melanoma and MAPK Pathways (3 papers), Protein Structure and Dynamics (2 papers), Computational Drug Discovery Methods (2 papers) and Microbial metabolism and enzyme function (2 papers). The work is most often cited by research in Cancer Research (88 citations), Molecular Biology (361 citations) and Complementary and alternative medicine (43 citations). Ashwini K. Devkota has collaborated with scholars based in United States and China. Frequent co-authors include Kevin N. Dalby, Tamer S. Kaoud, Eun Jeong Cho, Yadhu N. Singh, Mangalika Warthaka, Olga Abramczyk, Clint D.J. Tavares, Bülent Özpolat, Ramakrishna Edupuganti and Pengyu Ren. Their work appears in journals such as Biochemistry, Cancer Research and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026